Всероссийская GMP-конференция | NANOLEK
NANOLEK

Session partner

127055, Moscow,
Butyrskiy Val, 68/70, bldg. 1
Baker Plaza Business Center,
floor 2, office 24

E-mail: info@nanolek.ru, press@nanolek.ru

Tel: +7 (495) 648-26-87

www.nanolek.ru

NANOLEK IS A MODERN FAST-EVOLVING RUSSIAN BIOPHARMACEUTICAL COMPANY WITH ITS OWN HIGH-TECH COMPLETE CYCLE PRODUCTION COMPLIANT WITH GMP AND ISO. NANOLEK SPECIALIZES IN THE PRODUCTION OF IMPORT-SUBSTITUTING AND INNOVATIVE PHARMACEUTICALS, BOTH IN-HOUSE DEVELOPED AND INVENTED WITH THE HELP OF INTERNATIONAL PARTNERS, WITH A FOCUS ON THE PREVENTION AND TREATMENT OF SOCIALLY SIGNIFICANT DISEASES. THE COMPANY HAS UNIQUE EXPERIENCE IN THE AREA OF TRANSFER OF TECHNOLOGIES AS PART OF PARTNERSHIP WITH THE LEADING INTERNATIONAL PHARMACEUTICAL COMPANIES (MERCK, SANOFI, NOVARTIS, EGIS, ASPEN, CELLTRION, RIEMSER, ETC.)

The company is now one of the Russia’s leading producers of paediatric vaccines. NANOLEK’s diversified drug portfolio covers the following therapeutic areas: vaccines, drugs for treatment of HIV, oncological diseases, etc.

In 2020, Nanolek LLC was included in the list of systemic companies in Russia.